DnaK/DnaJ/GrpE of Hsp70 system have differing effects on alpha-synuclein fibrillation involved in Parkinson's disease

Atta Ahmad1

  • 1Department of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064, USA. ahmadatt@umich.edu

Insights

Molecular chaperones from the Hsp70 system show varied effects on alpha-synuclein aggregation, a key factor in Parkinson's disease. Initial protein conformation, not just chaperone activity, influences aggregation.

Area of Science:

  • Molecular biology
  • Neuroscience
  • Protein biochemistry

Background:

  • Molecular chaperones are crucial for maintaining proteome function in vivo.
  • Chaperones are often overwhelmed by protein misfolding diseases like Parkinson's, Huntington's, and Alzheimer's.
  • Previous studies on the Hsp70 system's role in proteinopathies were limited, examining only one or two components.

Purpose of the Study:

  • To characterize the in vitro effects of individual Hsp70 system components on alpha-synuclein aggregation.
  • To investigate the role of the Hsp70 system in Parkinson's disease pathogenesis.
  • To determine the influence of initial alpha-synuclein conformation on aggregation.

Main Methods:

  • Size exclusion chromatography (SEC) was used to analyze protein interactions and aggregation.
  • Thioflavin T (ThT) assay was employed to quantify the extent of alpha-synuclein aggregation.
  • In vitro characterization of each Hsp70 system component's effect on alpha-synuclein.

Main Results:

  • Different components of the Hsp70 system exhibited distinct effects on alpha-synuclein aggregation.
  • Some Hsp70 components were found to enhance alpha-synuclein aggregation.
  • Other Hsp70 components demonstrated a stabilizing effect, inhibiting alpha-synuclein aggregation.

Conclusions:

  • The Hsp70 system's components have differential impacts on alpha-synuclein aggregation.
  • The initial conformation of alpha-synuclein plays a critical role in triggering aggregation, even with the Hsp70 system intact.
  • Understanding these interactions is vital for developing therapeutic strategies for Parkinson's disease.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...